Request Call Back
Endoscopic Obesity Treatment: Intragastric Botox and Intragastric Balloon Applications
What is Endoscopic Obesity Treatment?
Endoscopic obesity treatment refers to non-surgical, minimally invasive procedures that aim to support weight loss in individuals struggling with obesity or being overweight. These procedures are performed using an endoscope—a flexible tube equipped with a camera—inserted through the mouth to access the stomach. The two most widely used methods in this category are intragastric botox injection and intragastric balloon placement.
These treatments work by either reducing the stomach’s capacity or delaying its emptying, thereby helping individuals feel fuller for longer and consume less food during meals. Unlike surgical bariatric options, these methods do not involve incisions or permanent anatomical changes, making them appealing to patients who are not candidates for surgery or prefer less invasive approaches.
Intragastric Botox
In the intragastric botox procedure, botulinum toxin (botox) is injected into the smooth muscle layer of the stomach, particularly in the fundus and antrum regions. Botox temporarily reduces gastric muscle contractions, slows gastric emptying, and prolongs the feeling of fullness after meals.
· Procedure time: Approximately 15–20 minutes
· Effect duration: Around 4–6 months
· Outcome: Helps initiate weight loss when combined with diet and exercise
Botox treatment is especially useful for those in the early stages of obesity or individuals seeking to lose moderate weight without surgery.
Intragastric Balloon
The intragastric balloon is a saline- or air-filled medical-grade silicone balloon placed into the stomach via endoscopy and then inflated. It occupies space in the stomach, leading to earlier satiety and a significant reduction in food intake.
· Volume occupied: Approximately 400–700 mL
· Duration of placement: Typically 6 to 12 months
· Outcome: Average weight loss of 10–15% of total body weight over the treatment period
Both procedures are performed on an outpatient basis under sedation, and patients can usually return to daily activities within a short time.
When Are Intragastric Botox and Balloon Applied?
These endoscopic weight loss methods are indicated for people who:
· Have a Body Mass Index (BMI) above 27
· Are unable to lose weight through diet and exercise alone
· Are not suitable for bariatric surgery or prefer non-surgical options
· Need preoperative weight loss to reduce risks before major surgeries
Suitable BMI Ranges:
· Intragastric Botox: Ideal for patients with BMI between 27 and 35
· Intragastric Balloon: Recommended for patients with BMI above 30, especially those needing stronger support for sustained weight loss
Other Considerations:
These procedures can also be considered for:
· Individuals with metabolic syndrome
· Patients with insulin resistance or pre-diabetes
· People at high risk of obesity-related complications such as type 2 diabetes, hypertension, or fatty liver disease
Importantly, these treatments are not permanent solutions. They are tools to initiate weight loss, which should be supported with lifestyle changes for long-term success.
The Procedure in Detail
Intragastric Botox Application
· Performed under sedation using an upper gastrointestinal endoscope
· Botox is injected into 20–30 targeted sites in the gastric muscle wall
· No incisions or hospital stay required
· Most patients experience no major side effects
· Minimal recovery time, and normal activities can often resume within 24 hours
Effectiveness: Weight loss with intragastric botox is typically modest, but it plays a crucial role in motivating behavioral changes, especially when paired with structured nutritional counseling.
Intragastric Balloon Placement
· The deflated balloon is inserted via endoscopy and inflated with sterile saline (or air)
· It remains in the stomach for 6 to 12 months
· Patients may experience temporary side effects such as nausea, bloating, or mild abdominal cramps during the first few days
· Nutritional support and regular medical monitoring are essential during the treatment period
After the intended duration, the balloon is deflated and removed endoscopically. Removal is usually straightforward and performed under similar conditions as the placement.
Effectiveness: Patients typically lose 10–15% of their total body weight, with improvements in blood sugar control, lipid profile, and blood pressure also observed.
Safety and Limitations
Both intragastric botox and balloon applications are considered safe when performed by experienced gastroenterologists in a controlled setting. However, some considerations must be taken into account:
Potential Side Effects:
· Botox: Rare and mild (nausea, bloating)
· Balloon: More common but temporary (gastric discomfort, vomiting, reflux)
Contraindications Include:
· History of gastrointestinal surgery or ulcers
· Severe gastric motility disorders
· Active H. pylori infection (should be treated first)
· Pregnancy or breastfeeding
Important Note: Neither treatment should be seen as a stand-alone solution. Their success depends heavily on patient compliance, lifestyle changes, and continued follow-up with dietitians and healthcare providers.
Conclusion
Endoscopic obesity treatments like intragastric botox and intragastric balloon offer safe, effective, and non-surgical solutions for individuals struggling with excess weight. These procedures work by modifying stomach function—either by reducing muscle contractions or occupying stomach volume—to help individuals feel full sooner and consume less.
Both methods serve as stepping stones toward sustainable weight management, especially when paired with nutritional guidance, physical activity, and behavioral change support.
With the right patient selection and multidisciplinary care, these techniques can significantly improve health outcomes, boost quality of life, and reduce obesity-related health risks.
